Search Results 541-550 of 19751 for autoimmune hepatitis
Mayo researchers were among the first to identify nonalcoholic fatty liver disease and primary sclerosing cholangitis. Mayo researchers also are making ...
This form is transmitted primarily by blood infected with the virus. An estimated 3.5 million people in the U.S. have chronic hepatitis C ─ sometimes leading ...
This is a story about beating the odds. The woman you're about to meet was diagnosed with pancreatic cancer and told she had months to live.
Sexual partners of persons with hepatitis B. Persons who may be exposed to the virus by means of blood, blood products, or human bites, such as health care ...
A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label- ...
Imaging of Fontan-Associated Liver Disease. J Comput Assist Tomogr. 2024 Jan-Feb 01; 48(1):1-11. Epub 2023 Aug 10. View PubMed; Kim YY ...
This condition causes small, painful lumps to form where your skin rubs together. The lumps heal and return and can lead to the formation of tunnels and ...
No patient enrollment will occur at MDACC. All patient recruitment will occur at external sites that are a part of the CPDPC. The data management systems, ...
The research program of Alina M. Allen, M.D., at Mayo Clinic is focused on improving outcomes for patients with nonalcoholic fatty liver disease (NAFLD).
antigen [HBsAg] positive), chronic hepatitis C virus (HCV) RNA positive, drug-induced liver injury (DILI), biliary obstruction, and autoimmune liver disease.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift today can have 5X the impact on AI research and technology. But hurry — the match challenge ends 9/19.